Ketogenic Supplement Metabolic Shift for Aging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for addressing age-related diseases lack effective prevention and treatment strategies based on a comprehensive understanding of the aging process, with existing treatments often focusing on specific diseases rather than the underlying aging mechanisms.
Innovation Solution
Administration of a ketogenic supplement, such as ketone esters or medium chain triglycerides, in high enough quantities to significantly alter metabolic pathways, reducing insulin-like growth factor-1 (IGF-1) and insulin levels, and increasing ketone bodies, thereby addressing the root causes of age-related conditions like anemia, hypoalbuminemia, and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional disease-specific treatments are used for age-related conditions, then specific disease symptoms are addressed, but the underlying aging process and multiple age-related conditions remain untreated
Solution Approach 1:
The patent applies universality by using ketone supplements as a single intervention that addresses multiple age-related conditions simultaneously. The ketogenic supplement targets the fundamental aging process rather than individual diseases, making it applicable to cancer, cardiovascular disease, neurodegenerative diseases, and other age-related conditions. This multi-functional approach allows one treatment to provide broad protective effects across various age-related pathologies.
Solution Approach 2:
The patent extracts the core aging mechanism from the complex web of age-related diseases and targets it directly. By identifying and addressing the fundamental metabolic and cellular changes of aging (such as mitochondrial dysfunction, oxidative stress, and metabolic syndrome), the treatment removes the root cause that drives multiple diseases, rather than treating each disease separately.
2Reliability
If high doses of ketogenic supplement are administered to significantly alter metabolic pathways, then IGF-1 and insulin levels are reduced and ketone bodies increase, but the dosage and metabolic shift must be carefully controlled
Solution Approach 1:
The patent applies parameter changes by systematically adjusting the dosage of ketogenic supplements to achieve optimal metabolic transformation. The invention specifies administering ketone supplements in amounts sufficient to elevate blood ketone levels to therapeutic ranges (e.g., 3-10 mM), thereby transforming the body's metabolic state from glucose-dependent to ketone-dependent. This controlled parameter adjustment ensures reliable metabolic pathway alteration while maintaining safety.
3Adaptability or versatility
If ketogenic supplement is used to address root causes of age-related conditions, then broader prevention and treatment coverage is achieved, but more research and understanding of aging mechanisms are required
Solution Approach 1:
The patent applies self-service by enabling the body's own metabolic systems to address aging-related damage. Ketone supplementation activates endogenous protective mechanisms, including upregulation of mitochondrial biogenesis, enhancement of autophagy, and activation of sirtuins and other longevity pathways. The body uses the ketone bodies to fuel cells, reduce inflammation, and repair damage without requiring external intervention beyond the supplement administration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ketogenic supplement effectively reduces IGF-1 and insulin levels, improves recovery time from infections, and mitigates age-related diseases by shifting systemic metabolism and attenuating tumor burden and muscle wasting, demonstrating a broader approach to treating age-related conditions.
Implementation Method 1
Administration of a ketogenic supplement, such as ketone esters or medium chain triglycerides, in high enough quantities to significantly alter metabolic pathways, reducing insulin-like growth factor-1 (IGF-1) and insulin levels, and increasing ketone bodies
Data Source
AI summary
Methods and compositions for preventing, reducing, delaying, or reversing effects due to aging or preventing, treating, or reducing time to recovery from a disease associated with aging, as well as anemia, hypoalbuminemia, hypoc-holesterolemia, malnutrition/anorexia/starvation, and/or splenomegaly in a subject in need thereof are disclosed. The method can include administering a therapeutically effective amount of a ketogenic supplement to the subject, wherein the subject is fed ad libitum. The ketogenic supplement can include R, S 1,3-butanediol acetoacetate diester or derivatives thereof.